Treatment Persistence Between Long-Acting Injectable versus Oral Aripiprazole among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).